Dupilumab for Atopic Dermatitis

Dupilumab (brand name Dupixent) is shaping up to be a game-changer in the treatment of atopic dermatitis, often referred to informally as “eczema”. Dupixent addresses an underlying immune dysregulation that contributes to the development of atopic dermatitis. It blocks IL-4 and IL-13, two important cytokines in the TH2 pathway. In a clinical trial, after 12… Read More

Prurigo Nodularis – A Frustrating Problem

Prurigo nodularis (PN) describes a skin condition with firm itchy nodules, in which the skin changes are thought to be secondary to the repetitive trauma of scratching. The lesions can be skin-colored, brown, or red, sometimes with scale, crust, or erosion and ulceration. Lesions of prurigo nodularis are typically on the extensor aspects of the… Read More

Nicotinamide For Skin Cancer Prevention

For those at high risk of developing nonmelanoma skin cancers (NMSC), namely basal cell carcinoma or squamous cell carcinoma, a simple nutritional supplement may reduce the long-term risk. Nicotinamide, a water-soluble form of vitamin B3, has been shown to reduce the incidence of nonmelanoma skin cancer in certain patients. Several studies have shown that 500… Read More

Treatment of Chronic Urticaria (Hives)

Treatment of Urticaria (Hives) Most people will have a bout of hives in their lives. The causes of hives are many, including medications, infections, and physical inducers such as cold, heat, pressure, and sunlight, but for many cases a specific cause cannot be identified. Urticaria is typically classified as acute (<6 weeks) or chronic (>6… Read More

Tranexamic Acid For Melasma

Recently there has been a lot of excitement about the use of tranexamic acid for the treatment of melasma. Tranexamic acid is currently FDA-approved by prescription for the treatment of heavy menstrual bleeding, but off-label studies suggest that it is effective in the treatment of melasma when used at a low dose of 250 to… Read More

Eskata for Seborrheic Ketatoses

Eskata, a new treatment for seborrheic keratoses (SK) has been approved by the Food & Drug Administration. Eskata is a 40% solution of hydrogen peroxide with a custom applicator. In each treatment, each lesion may be treated up to four times, a minute apart. The treatment may be repeated several weeks later. Eskata joins other… Read More

SculpSure for Double Chin

SculpSure in September 2017 was approved by the FDA for non-invasive contouring of the submental area–usually known as a double chin. This requires an additional hand-piece for the SculpSure device, which was originally approved for non-invasive body contouring. The specialized hand-piece holds the applicator in place in the submental area. For the SculpSure submental approval,… Read More

Eczema Therapeutic Ladder

Call 973-763-7546 To Schedule Your Eczema Consultation Atopic dermatitis, usually called eczema, is one of the most common conditions encountered in dermatology, with itch typically the paramount symptom. Treating atopic dermatitis usually starts with a gradual escalation of treatments up the therapeutic ladder. Topical Therapies For Atopic Dermatitis Emollients and Skin Care.  The use of… Read More

Itchy Scalp (Scalp Pruritus)

Call 973-763-7546 For Your Itchy Scalp Consultation Now What is itchy scalp? Many people suffer from chronic itching of the scalp, a problem that can profoundly impact quality of life. Itchy scalp does not have one cause. The most common causes are: seborrheic dermatitis, psoriasis, contact dermatitis, and neuropathic itch. What else can cause an… Read More

Restylane Refyne and Defyne Fillers Approved

Galderma has received U.S. Food and Drug Administration (FDA) approval of two new products for the treatment of nasolabial folds (NLF) or “laugh lines.”  Restylane® Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane Defyne for the treatment of moderate to severe, deep facial wrinkles and folds. Refyne… Read More